Stock STAA STAAR SURGICAL COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials STAAR Surgical Company

Equities

STAA

US8523123052

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
46.96 USD +0.15% Intraday chart for STAAR Surgical Company +1.23% +50.46%
Apr. 11 Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating MT
Apr. 08 Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,628 3,560 4,414 2,309 1,523 2,260 - -
Enterprise Value (EV) 1 1,628 3,560 4,414 2,309 1,302 1,967 1,946 2,260
P/E ratio 122 x 644 x 185 x 60.6 x 72.6 x 2,609 x 104 x 62.6 x
Yield - - - - - - - -
Capitalization / Revenue 10.8 x 21.8 x 19.2 x 8.12 x 4.72 x 6.67 x 5.73 x 4.79 x
EV / Revenue 10.8 x 21.8 x 19.2 x 8.12 x 4.04 x 5.81 x 4.93 x 4.79 x
EV / EBITDA 105 x - 85.6 x 33.6 x 23 x 53.8 x 31 x 23.9 x
EV / FCF 104 x 284 x 146 x 131 x -362 x 242 x 96.7 x 103 x
FCF Yield 0.96% 0.35% 0.69% 0.76% -0.28% 0.41% 1.03% 0.97%
Price to Book - - - - 4 x 5.49 x 5.07 x -
Nbr of stocks (in thousands) 44,598 46,099 47,597 48,202 48,805 48,117 - -
Reference price 2 36.50 77.22 92.74 47.91 31.21 46.96 46.96 46.96
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 150.2 163.5 230.5 284.4 322.4 338.7 394.4 471.3
EBITDA 1 15.55 - 51.59 68.68 56.74 36.59 62.78 94.53
EBIT 1 11.85 6.769 33.34 43.8 28.1 2.451 32.15 54.35
Operating Margin 7.89% 4.14% 14.47% 15.4% 8.71% 0.72% 8.15% 11.53%
Earnings before Tax (EBT) 1 13.03 8.267 31.3 45.8 33.7 3.526 35.5 57.34
Net income 1 14.05 5.913 24.5 39 21.35 0.8692 26.15 37.89
Net margin 9.35% 3.62% 10.63% 13.72% 6.62% 0.26% 6.63% 8.04%
EPS 2 0.3000 0.1200 0.5000 0.7900 0.4300 0.0180 0.4533 0.7500
Free Cash Flow 1 15.7 12.55 30.32 17.61 -3.594 8.121 20.13 22
FCF margin 10.45% 7.68% 13.15% 6.19% -1.11% 2.4% 5.1% 4.67%
FCF Conversion (EBITDA) 100.96% - 58.77% 25.64% - 22.19% 32.06% 23.27%
FCF Conversion (Net income) 111.76% 212.19% 123.74% 45.14% - 934.31% 76.95% 58.06%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 58.35 59 63.2 81.1 76.05 64.04 73.53 92.31 80.31 76.27 74.65 95.33 86.89 81.86 83.41
EBITDA 1 12.43 11.95 13.12 23.81 20.52 7.345 9.985 18.47 16.48 11.95 0.5429 16.84 11.53 7.729 5.8
EBIT 1 7.837 7.383 12.11 17.02 13.7 0.964 2.8 8.597 6.295 10.4 -7.898 8.107 2.868 -0.5083 -0.1282
Operating Margin 13.43% 12.51% 19.17% 20.99% 18.02% 1.51% 3.81% 9.31% 7.84% 13.64% -10.58% 8.5% 3.3% -0.62% -0.15%
Earnings before Tax (EBT) 1 7.376 6.974 11.53 15.47 12.58 6.229 4.719 8.492 6.746 13.74 -7.473 8.522 2.84 -0.3725 0.7818
Net income 1 6.02 4.922 9.602 13.04 10.26 6.103 2.71 6.064 4.817 7.756 -5.498 5.311 1.596 -0.5301 0.154
Net margin 10.32% 8.34% 15.19% 16.08% 13.49% 9.53% 3.69% 6.57% 6% 10.17% -7.36% 5.57% 1.84% -0.65% 0.18%
EPS 2 0.1200 0.1000 0.1900 0.2600 0.2100 0.1200 0.0500 0.1200 0.1000 0.1600 -0.1090 0.1050 0.0310 -0.0100 0.004000
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/3/21 2/23/22 5/4/22 8/10/22 11/2/22 2/21/23 5/3/23 8/2/23 11/1/23 2/26/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - - 221 292 313 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 15.7 12.5 30.3 17.6 -3.59 8.12 20.1 22
ROE (net income / shareholders' equity) 8.79% 3.31% 10.8% 13.2% 5.91% 5.57% 8.43% -
ROA (Net income/ Total Assets) 6.79% 2.54% 8.12% 10.3% 4.7% 0.95% 6.25% -
Assets 1 206.9 232.5 301.6 380.5 453.8 91.49 418.5 -
Book Value Per Share 2 - - - - 7.810 8.550 9.260 -
Cash Flow per Share 2 - - - - - 0.7100 0.6600 -
Capex 1 10.1 8.4 13.6 18.1 18.2 27 27.5 23
Capex / Sales 6.72% 5.14% 5.92% 6.37% 5.64% 7.97% 6.97% 4.88%
Announcement Date 2/26/20 2/24/21 2/23/22 2/21/23 2/26/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for STAAR Surgical Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
46.96 USD
Average target price
49.17 USD
Spread / Average Target
+4.70%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
STAAR SURGICAL COMPANY Stock STAAR Surgical Company
+50.46% 2.26B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. STAA Stock
  4. Financials STAAR Surgical Company